No connection

Search Results

BFLY vs IRMD

BFLY
Butterfly Network, Inc.
NEUTRAL
Price
$4.51
Market Cap
$1.14B
Sector
Healthcare
AI Confidence
65%
IRMD
IRADIMED CORPORATION
NEUTRAL
Price
$93.40
Market Cap
$1.19B
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
BFLY
--
IRMD
53.37
Forward P/E
BFLY
-32.8
IRMD
40.26
P/B Ratio
BFLY
5.59
IRMD
12.62
P/S Ratio
BFLY
12.88
IRMD
14.24
EV/EBITDA
BFLY
-16.66
IRMD
41.84

Profitability

Gross Margin
BFLY
62.92%
IRMD
76.75%
Operating Margin
BFLY
-69.69%
IRMD
31.26%
Profit Margin
BFLY
-90.31%
IRMD
26.82%
ROE
BFLY
-41.42%
IRMD
24.78%
ROA
BFLY
-14.35%
IRMD
15.78%

Growth

Revenue Growth
BFLY
4.5%
IRMD
17.0%
Earnings Growth
BFLY
--
IRMD
24.8%

Financial Health

Debt/Equity
BFLY
0.1
IRMD
--
Current Ratio
BFLY
4.8
IRMD
7.98
Quick Ratio
BFLY
3.35
IRMD
6.37

Dividends

Dividend Yield
BFLY
--
IRMD
0.86%
Payout Ratio
BFLY
0.0%
IRMD
38.86%

AI Verdict

BFLY NEUTRAL

Butterfly Network (BFLY) shows a Piotroski F-Score of 5/9, indicating stable but not strong financial health, while the absence of an Altman Z-Score prevents a definitive bankruptcy risk assessment. Despite deeply negative profitability metrics—including a -90.31% profit margin and negative ROE/ROA—the company maintains strong liquidity (Current Ratio: 4.80) and a low Debt/Equity ratio of 0.10. Revenue growth is modest at 4.50% YoY, but earnings surprises have been consistently positive in recent quarters, suggesting operational improvements. However, aggressive insider selling worth $21.71M over the past six months contradicts the 'strong_buy' analyst consensus and raises concerns about insider confidence.

Strengths
Strong liquidity position with Current Ratio of 4.80 and Quick Ratio of 3.35
Low leverage with Debt/Equity ratio of 0.10, well below sector average of 2.28
High gross margin of 62.92%, indicating pricing power or efficient production
Risks
Piotroski F-Score of 5 indicates borderline financial stability; not strong enough to signal robust health
Severe unprofitability: -90.31% profit margin and -41.42% ROE suggest ongoing fundamental weaknesses
Negative Forward P/E of -32.80 implies no near-term earnings recovery priced in
IRMD NEUTRAL

IRMD presents a dichotomy between exceptional operational performance and extreme valuation premiums. While the Piotroski F-Score of 4/9 indicates stable financial health and the company boasts an impressive 76.75% gross margin and a consistent 25-quarter earnings beat record, the stock is trading significantly above its Graham Number ($17.07) and Intrinsic Value ($51.62). The strong fundamental growth is currently offset by bearish insider activity from the CEO and a completely bearish technical trend (0/100).

Strengths
Exceptional profitability with 76.75% gross margins and 26.82% profit margins
Strong return on equity (ROE) of 24.78%
Outstanding liquidity position with a current ratio of 7.98
Risks
Severe valuation stretch with a P/E of 53.37 and P/S of 14.24
Bearish insider sentiment with the CEO selling $9.44M in shares
Technical trend is currently 0/100, indicating strong bearish momentum

Compare Another Pair

BFLY vs IRMD: Head-to-Head Comparison

This page compares Butterfly Network, Inc. (BFLY) and IRADIMED CORPORATION (IRMD) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile